Belantamab (Anti-TNFRSF17 / BCMA / CD269)
Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2328 |
Sku # | A2328-1mg |
Pricing | 1mg, $370.00 |